Back to Search
Start Over
Ladenburg starts Liquidia Technologies at Buy with $15 price target
- Source :
- The Fly. July 22, 2022
- Publication Year :
- 2022
-
Abstract
- Ladenburg analyst Matt Kaplan initiated coverage of Liquidia Technologies (LQDA) with a Buy rating and $15 price target. Lead asset Yutrepia is a dry powder inhaler of treprostinil being developed [...]
- Subjects :
- Treprostinil
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.711100697